{"id":"W4353076861","doi":"10.51731/cjht.2023.603","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Chemotherapy; Oncology; Disease; Internal medicine; Breast cancer; Test (biology); Family medicine; Cancer; Health care; Immunotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005362437,0.0002434981,0.0002427454,0.0005722989,0.0002130906,0.0006746764,0.0003402939,0.000478947,0.01470073],"category_scores_gemma":[0.001035667,0.00008418979,0.0003783251,0.0003646622,0.0002287085,0.0005419305,0.0003156938,0.0006536943,0.00293632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001239918,"about_ca_system_score_gemma":0.001412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01032859,"about_ca_topic_score_gemma":0.03074959,"domain_scores_codex":[0.9997484,0.00005567409,0.00002936158,0.00004139249,0.00008879632,0.00003645365],"domain_scores_gemma":[0.9997014,0.00006760182,0.00008528249,0.00001294716,0.00009334285,0.00003933778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006277532,0.00005290265,0.0005756749,0.003390296,0.0001150822,0.000127237,0.0000234825,0.0001001507,0.003165815,0.002754328,0.08207544,0.906992],"study_design_scores_gemma":[0.0004073666,0.000693544,0.005193246,0.002586242,0.0002193439,0.0008954587,0.00003494196,0.0001180645,0.004420797,0.0006102003,0.9848052,0.00001555291],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01342447,0.8154067,0.002053672,0.0119848,0.00220926,0.000363379,0.002877838,0.0003698131,0.15131],"genre_scores_gemma":[0.196829,0.6443436,0.007560398,0.01640976,0.001154643,0.0003779831,0.004179822,0.00005354934,0.1290913],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01470073,"threshold_uncertainty_score":0.0491789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03841720438725481,"score_gpt":0.3117376367690041,"score_spread":0.2733204323817493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}